Investigational drug · Phase 3
folinic acid
Not approved by FDA. In 4 industry-sponsored Phase 2 or 3 trials that are active or finished in the last two years, most often for Unresectable Metastatic Colorectal Cancer, Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer, Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer.
Phase 3Last checked: Nov 20, 2026Latest source record: Nov 9, 2026 (newest trial update)Source: ClinicalTrials.govMethods & limitations
Highest phase
Phase 3
Industry-sponsored trials
Phase 2 and 3 trials
4
4 still active
All registered trials
2,289
Any phase or sponsor naming "folinic acid"
First trial start
2018
Jun 21, 2018
Sponsors
Lead sponsors of its Phase 2 and 3 trials.
All registered trials by phase
Every ClinicalTrials.gov drug study naming "folinic acid", any sponsor or status.
Conditions studied
As listed on its trial records.
- Unresectable Metastatic Colorectal Cancer
- Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer
- Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer
- Metastatic Gastric Adenocarcinoma or Cancer
- Metastatic Gastroesophageal Junction (GEJ) Adenocarcinoma
- Pharmacokinetics of Zolbetuximab
- Gastric Cancer
- Gastro-esophageal Junction (GEJ) Cancer
- Pharmacokinetics of Oxaliplatin
- Pharmacokinetics of Fluorouracil Bolus (5-FU)
Approved drugs for the same conditions: Colorectal cancer · Stomach and esophageal cancer · Oncology · Gastroenterology and liver
Largest trials
Live from ClinicalTrials.gov: studies naming "folinic acid" as an intervention, largest first.
- Impact of Zinc Supplementation on Mortality and Hospitalizations in Children Aged 1 Months to 23 MonthsPivotal-lookingCompleted
Society for Applied StudiesAcademic, hospital or other
NCT00269542 · 94,359 participants · Start Feb 2002 · Primary completion Mar 2003
Drug: Zinc and iron folic acid - Intervention; Iron Folic Acid alone - Placebo · For: Morbidity; Mortality; Diarrhea and 1 more
- Community Trial of Zinc Supplementation on Preschool Child Mortality and Morbidity in Southern NepalPivotal-lookingCompleted
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)NIH
NCT00109551 · 58,000 participants · Start Oct 2001
Drug: zinc sulphate dietary supplement; iron sulphate-folic acid dietary supplement · For: Nutrition
Sites: Baltimore, Maryland; Ithaca, New York; Kathmandu and Sarlahi District, Nepal
- China Stroke Primary Prevention Trial 2 for Participants With H-type Hypertension and MTHFR 677 CC/CT Genotype (CSPPT2-CC/CT)Pivotal-lookingRecruiting
Shenzhen Ausa Pharmed Co.,LtdIndustry
NCT04974138 · 32,000 participants (planned) · Start Aug 22, 2024 · Primary completion Jun 30, 2030
Drug: Amlodipine besylate; Amlodipine besylate and folic acid and 2 more · For: Hypertension; MTHFR 677 CC or CT Genotype; Elevated Plasma Homocysteine (Hcy≥10µmol/L) and 1 more
Sites: Bengbu, China; Bozhou, China; Chizhou, China · 20 sites in all
- China Stroke Primary Prevention Trial 2 for Participants With Hypertension and MTHFR 677 TT GenotypePivotal-lookingRecruiting
Shenzhen Ausa Pharmed Co.,LtdIndustry
NCT04974151 · 24,000 participants (planned) · Start Aug 22, 2024 · Primary completion Jun 30, 2029
Drug: Amlodipine besylate; Amlodipine besylate And Folic Acid and 4 more · For: Hypertension; MTHFR 677 TT Genotype
Sites: Bengbu, China; Bozhou, China; Chizhou, China · 20 sites in all
- China Stroke Primary Prevention TrialPivotal-lookingCompleted
Shenzhen Ausa Pharmed Co.,LtdIndustry
NCT00794885 · 20,702 participants · Start May 2008 · Primary completion Aug 2013
Drug: Enalapril/folic acid; Enalapril maleate · For: Primary Hypertension
Sites: Anqing, China; Lianyungang, China
- Folic Acid and Intensive Antihypertensive Therapy for Hypertension With CSVDPivotal-lookingNot yet recruiting
Beijing Tiantan HospitalAcademic, hospital or other
NCT05169021 · 15,000 participants (planned) · Start Dec 31, 2021 · Primary completion Dec 31, 2024
Drug: Amlodipine folic acid 5.8mg+intensive antihypertensive therapy; Amlodipine folic acid 5.8mg+standard antihypertensive therapy and 2 more · For: Cerebral Small Vessel Diseases; Stroke
Sites: Beijing, China
- Study of the Effectiveness of Additional Reductions in Cholesterol and HomocysteinePivotal-lookingCompleted
University of OxfordAcademic, hospital or other
NCT00124072 · 12,064 participants · Start Jul 1998 · Primary completion May 2008
Drug: Simvastatin 20 mg daily; Simvastatin 80 mg daily and 1 more · For: Cardiovascular Disease
Sites: Oxford, United Kingdom
- Risk-Adapted Chemotherapy in Treating Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia or Localized B-Lineage Lymphoblastic LymphomaPivotal-lookingCompleted
Children's Oncology GroupResearch network
NCT01190930 · 9,350 participants · Start Aug 11, 2010 · Primary completion Mar 31, 2019
Drug: Cyclophosphamide; Cytarabine and 8 more · For: Acute Lymphoblastic Leukemia; Adult B Lymphoblastic Lymphoma; Ann Arbor Stage I B Lymphoblastic Lymphoma and 7 more
Sites: Birmingham, Alabama; Mobile, Alabama; Anchorage, Alaska · 243 sites in all
- VITATOPS: A Study of VITAmins TO Prevent StrokePivotal-lookingCompleted
VITATOPSGovernment (non-federal)
NCT00097669 · 8,164 participants · Start Nov 1998 · Primary completion Jun 2009
Drug: Active VITATOPS Tablet (folic acid 2mg, B6 25mg , B12 500ug) or placebo · For: Stroke; Transient Ischemic Attack
Sites: New York, New York; Abington, Pennsylvania; Columbia, South Carolina · 111 sites in all
- A Study to Investigate Blinatumomab in Combination With Chemotherapy in Patients With Newly Diagnosed B-Lymphoblastic LeukemiaPivotal-lookingActive, not recruiting
National Cancer Institute (NCI)NIH
NCT03914625 · 6,720 participants (planned) · Start Jul 3, 2019 · Primary completion Sep 30, 2027
Drug: Asparaginase Erwinia chrysanthemi; Blinatumomab and 13 more · For: B Acute Lymphoblastic Leukemia; B Lymphoblastic Lymphoma; Down Syndrome
Sites: Birmingham, Alabama; Mobile, Alabama; Anchorage, Alaska · 228 sites in all
Newest research
PubMed records naming it or its code names, newest first.
- Safety and efficacy of the FOLFOX regimen in patients with metastatic gastrointestinal cancers and severe hyperbilirubinemia: A real-world experience.
Başkurt K, Uyar GC, Yeşilbaş E, et al. · Oncol Lett 2026
- Hot spot-driven discovery of β-catenin/Tcf4 interaction inhibitors via virtual drug repurposing study and experimental validation in colorectal cancer cells.
Sahin K, Coker A, Durdağ S · Mol Divers 2026
- Spinal toxoplasmosis presents as myelitis in a patient with systemic lupus erythematosus and immunosuppression: a case report.
Lakshman P, Krishnamoorthy S, Gan P, et al. · BMJ Neurol Open 2026
- Fluorouracil-Associated Coronary Vasospasm and Reversible Cardiomyopathy Mimicking ST-Elevation Myocardial Infarction During a First Cycle of FOLFOX: A Case Report.
Alyacoub R, Veras Victoria A · Am J Case Rep 2026
- Synthesis and biological evaluation of pyridine-based derivatives as potential inhibitors of Leishmania major propagation.
Sabt A, Bekhit AA, Farag H, et al. · RSC Adv 2026
- Adverse event signals associated with targeted therapy plus chemotherapy in colorectal cancer: A FAERS-based pharmacovigilance study.
Liu Y, Li Z, Li G, et al. · Medicine (Baltimore) 2026
Also in development for Unresectable Metastatic Colorectal Cancer
- Telisotuzumab AdizutecanABBV-400Phase 316 trials
AbbVie · c-MET, Non-Squamous Non-Small Cell Lung Cancer, Metastatic Colorectal Cancer
- STC-1010Phase 21 trial
Brenus Pharma · Unresectable Metastatic Colorectal Cancer, Unresectable Locally Advanced Colorectal Cancer
Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do. More from Astellas.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.